(Q46000401)

18 December 2017

title

Flow-independent nitric oxide exchange parameters in cystic fibrosis. (English)

1 reference

18 December 2017

0 references

Hye-Won Shin

1

1 reference

18 December 2017

Christine M Rose-Gottron

2

1 reference

18 December 2017

Ramindrjit S Sufi

3

1 reference

18 December 2017

Federico Perez

4

1 reference

18 December 2017

Dan M Cooper

5

1 reference

18 December 2017

Archie F Wilson

6

1 reference

18 December 2017

Steven C George

7

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

18 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

18 December 2017

volume

165

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

349-357

1 reference

18 December 2017

Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

A significant proportion of exhaled nitric oxide arises in large airways in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Nitric oxide in exhaled air.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Exhaled nitric oxide in paediatric asthma and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Reduced upper airway nitric oxide in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Cystic fibrosis lung disease: the role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Nitric oxide metabolites in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Increased nitric oxide in exhaled air of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

Exhaled Nitric Oxide after β2-agonist Inhalation and Spirometry in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2105098

10.1164/AJRCCM.165.3.2105098

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

11818320

1 reference

18 December 2017